NPI: 1457315012 · EL PASO, TX 79924 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/12/2006
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 04/12/2006 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 10,678 | $124K |
| 2019 | 3,987 | $78K |
| 2020 | 1,830 | $39K |
| 2021 | 5,473 | $42K |
| 2022 | 8,532 | $55K |
| 2023 | 5,978 | $152K |
| 2024 | 2,160 | $143K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 14,299 | 1,264 | $614K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 12,816 | 759 | $7K |
| J1270 | Injection, doxercalciferol, 1 mcg | 2,964 | 271 | $4K |
| A4657 | Syringe, with or without needle, each | 1,452 | 1,109 | $3K |
| J1756 | Injection, iron sucrose, 1 mg | 406 | 101 | $3K |
| 83970 | 647 | 535 | $1K | |
| 82728 | 1,176 | 957 | $499.30 | |
| 83550 | 933 | 770 | $322.20 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 87 | 55 | $302.59 |
| 83540 | 1,085 | 903 | $238.96 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 231 | 191 | $146.70 |
| G0008 | Administration of influenza virus vaccine | 20 | 19 | $62.40 |
| 85041 | 1,163 | 971 | $52.18 | |
| 82108 | 62 | 57 | $49.92 | |
| 85048 | 1,154 | 968 | $43.94 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 143 | 83 | $8.84 |